P/E at 59.56 vs Industry's 66.07: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount Amidst Sector Premiums

The hospital sector, characterised by steady demand and growth prospects, currently commands an industry average P/E of 66.07. Against this backdrop, Apollo Hospitals Enterprise Ltd.’s P/E of 59.56 signals a valuation discount of nearly 10%. This suggests that the market is pricing in either a more cautious outlook on the company’s earnings growth or perceives some risk factors not fully reflected in the broader sector. The premium enjoyed by the sector is often justified by robust earnings growth and defensive qualities, so the discount here invites scrutiny — what is the current rating for Apollo Hospitals given this valuation gap? The data implies that investors may be weighing recent performance trends more heavily than sector-wide optimism.

Performance Across Timeframes: Mixed Signals

Examining returns over multiple periods reveals a nuanced picture. Over the past year, Apollo Hospitals has delivered a 12.22% gain, outperforming the Sensex’s 4.73% loss. This outperformance extends over longer horizons, with three-year returns at 79.30% versus the Sensex’s 17.39%, and a remarkable ten-year return of 531.70% compared to 169.02% for the benchmark. Such figures underscore the company’s strong historical growth and resilience.

However, the short-term momentum is less encouraging. The stock has declined by 1.49% over the past week and 1.66% over the last month, while the Sensex fell by 0.23% and 2.39% respectively. The three-month return of 4.71% is positive but only marginally ahead of the Sensex’s 3.24%. This suggests a recent slowdown in momentum despite the longer-term strength — is this a temporary pause or a sign of deeper weakness? The stock’s three-day consecutive fall, amounting to a 1.64% loss, adds to the short-term caution.

Moving Average Configuration: A Mixed Technical Picture

The technical setup of Apollo Hospitals reveals a complex trend. The stock is trading above its 100-day and 200-day moving averages, signalling that the longer-term trend remains intact and positive. However, it is currently below the 5-day, 20-day, and 50-day moving averages, indicating short-term weakness or consolidation. This configuration often points to a recent pullback within an overall uptrend, suggesting that the stock may be undergoing a correction or a pause before potentially resuming its upward trajectory. The 5-day and 20-day averages are particularly sensitive to recent price action, so their breach signals caution — is this a genuine recovery or a dead-cat bounce? — the moving average configuration provides the clearest answer.

Sector Context: Hospital Industry Performance

The hospital sector has shown resilience amid varied economic conditions, with a majority of companies delivering positive results. The industry P/E of 66.07 reflects investor confidence in sustainable earnings growth. Within this context, Apollo Hospitals stands as a large-cap leader with a market capitalisation of ₹1,24,717.37 crores. The sector’s overall positive performance contrasts with the stock’s recent short-term softness, highlighting a divergence that merits attention. The sector’s strength is underpinned by steady demand for healthcare services, but individual stock performance can vary due to company-specific factors — should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Context: Previously Strong Buy, Now Reassessed

MarketsMOJO had previously assigned a Strong Buy rating to Apollo Hospitals Enterprise Ltd.. This rating was updated on 1 Sep 2026, reflecting a reassessment of the company’s fundamentals and market conditions. While the current rating is not disclosed, the change indicates a nuanced view of the stock’s prospects. The valuation discount relative to the sector, combined with mixed short-term performance and a complex moving average configuration, likely influenced this reassessment. Investors may find it useful to explore the detailed rating rationale — what is the current rating for Apollo Hospitals?

Conclusion: A Data-Driven Assessment

The data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a valuation discount to its sector, with strong long-term returns but recent short-term softness. The moving average configuration suggests a pause or correction within a longer-term uptrend. The sector remains robust, yet the stock’s recent performance and rating reassessment indicate a more cautious stance. Collectively, these factors highlight the importance of analysing multiple dimensions — valuation, performance, technicals, and sector context — before drawing conclusions about the stock’s outlook. Should investors in Apollo Hospitals hold, buy more, or reconsider?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →